Meta Health Limited (SGX:5DX) said it has used SG$882,000 of the SG$1.4 million raised from its renounceable non-underwritten rights issue, mainly for debt repayment and working capital, according to a Friday filing on the Singapore Exchange.
The healthcare technology firm allocated SG$790,000 for loan repayments, using SG$252,000 so far, including full repayment of a SG$150,000 loan from MWA Capital due March 2025.
Another SG$640,000 was set aside for corporate and working capital needs, of which SG$630,000 has been spent on employee expenses, legal fees, rental, and corporate costs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.